Take the free GLP-1 qualification quiz at https://go.telehealthfx.com/start — see if you are eligible for semaglutide or tirzepatide through a fully licensed clinical weight loss program with 1-on-1 onboarding, no hidden membership fees, and long-term clinical support. Learn more at https://telehealthfx.com or explore berberine options at https://go.telehealthfx.com/berberine.

⚖️ What really happens when you stop taking a GLP-1 medication like semaglutide or tirzepatide? In this episode of TelehealthFX Talk, we break down the clinical data on weight regain after GLP-1 discontinuation, explain the biology behind the rebound effect, and give you a complete 5-step maintenance playbook to protect your results — whether you are planning to stop, taper, or stay on long-term.

👇 HERE'S WHAT WE COVER 👇

• The STEP 1 extension trial data — participants lost an average of 17.3% body weight during 68 weeks of semaglutide treatment, but regained approximately two-thirds of that weight within one year of stopping. Net weight loss dropped from 17.3% to just 5.6%. Cardiometabolic improvements (blood pressure, cholesterol) also reverted toward baseline.

• 2026 meta-analysis findings — patients regain approximately 60% of lost weight within 52 weeks of stopping GLP-1 medication, eventually plateauing at roughly 75% regain. Most patients return to baseline weight within 1.5 to 1.7 years after cessation.

• The biology behind the rebound — when GLP-1 medication is removed, appetite suppression disappears, ghrelin (hunger hormone) rebounds often stronger than before, satiety signaling drops, "food noise" returns, and the body's metabolic set point actively works to restore lost weight. This is not a personal failure — it is a predictable physiological response.

• Sarcopenic obesity risk — regained weight after GLP-1 discontinuation tends to consist disproportionately of fat rather than muscle, potentially leaving patients with worse body composition than before treatment. This makes resistance training during and after treatment critically important.

• The obesity-as-chronic-disease framework — the medical community increasingly views GLP-1 medications as long-term disease management tools, similar to blood pressure or diabetes medication. Stopping without a structured plan carries high relapse risk.

• Your 5-step maintenance playbook:

• Work with your provider on a gradual tapering plan rather than stopping abruptly.

• Build your lifestyle foundation while still on medication — use the hormonal bridge to establish sustainable protein, exercise, and meal prep habits.

• Protein (1.2-1.6 g/kg daily) and resistance training (2-3x/week) are non-negotiable for protecting body composition.

• Plan for the return of food noise — stock high-fiber, high-protein foods and consider working with a dietitian.

• Set up an early warning system — weekly weigh-ins with a pre-defined threshold for contacting your provider.

⚠️ IMPORTANT DISCLAIMER ⚠️

This content is for educational purposes only and is not medical advice. Always consult with a licensed healthcare provider before starting, stopping, or changing any medication. Individual results may vary. Do not stop or change your medication without medical guidance.

#GLP1 #WeightLoss #Semaglutide #Tirzepatide #OzempicRebound #WeightRegain #GLP1Discontinuation #FoodNoise #TelehealthWeightLoss #TelehealthFX #OzempicAlternative #ClinicalWeightLoss #WeightManagement #WeightLossStruggles #GLP1ForWeightLoss #WeightLossDelivered #NoHiddenFees #NADTherapy #Sermorelin #WeightLossForWomen #WeightLossForSeniors #OnlineWeightLoss #ChronicObesity #WeightLossProgram #SarcopenicObesity #WeightLossMaintenance #StoppingOzempic